Erber, Ralf <br/><br/>
Combined inhibition of VEGF and PDGF signaling enforces tumor vessel regression by interfering with pericyte-mediated endothelial cell survival mechanisms.  [electronic resource] 

 -  FASEB journal : official publication of the Federation of American Societies for Experimental Biology  Feb 2004 
 - 338-40 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1530-6860 
<br/><br/><label>Standard No.: </label>10.1096/fj.03-0271fje  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Apoptosis<br/>Cell Survival--drug effects<br/>Hypoxia<br/>Indoles--pharmacology<br/>Microcirculation--drug effects<br/>Models, Biological<br/>Neoplasms--blood supply<br/>Neovascularization, Pathologic--drug therapy<br/>Oxindoles<br/>Pericytes--cytology<br/>Platelet-Derived Growth Factor--antagonists & inhibitors<br/>Propionates<br/>Pyrroles--pharmacology<br/>Receptor, Platelet-Derived Growth Factor beta--antagonists & inhibitors<br/>Signal Transduction--drug effects<br/>Vascular Endothelial Growth Factor A--antagonists & inhibitors<br/>Vascular Endothelial Growth Factor Receptor-2--antagonists & inhibitors